An R&D-driven biopharma company engaged in manufacturing fermentation-based active pharmaceutical ingredients for immunosuppressants and oncology applications. Established in 1984, the company specializes in complex fermentation technology and serves domestic and international pharmaceutical markets with differentiated API solutions. Its focus on bioprocess innovation and vertical integration in fermentation-based manufacturing distinguishes it within the competitive global pharmaceutical ingredients landscape.
Founder of Ohm Stock Broker with 27+ years in Indian capital markets. Was the 9th highest individual income-tax payer in India in FY2003-04, reflecting early success as a proprietary trader that few retail investors ever replicate. His ~₹244 Cr disclosed portfolio is heavily anchored in healthcare (Shilpa Medicare), alongside defence, deep-tech, and biotech, sectors where deep diligence matters more than market consensus.
